Provectus Biopharmaceuticals, Inc. (PVCT)
0.0459
0.00 (0.00%)
USD |
OTCM |
Feb 20, 15:21
Provectus Biopharmaceuticals Market Cap : 19.29M for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.060B |
| Alnylam Pharmaceuticals, Inc. | 44.59B |
| Savara, Inc. | 1.124B |
| BioMarin Pharmaceutical, Inc. | 12.31B |
| Imunon, Inc. | 6.811M |
Market Cap Related Metrics
| PS Ratio | 55.05 |
| PEG Ratio | -0.0247 |
| Price | 0.0459 |
| Earnings Yield | -34.20% |
| PEGY Ratio | -0.0247 |